BELLICUM PHARMACEUTICALS, INC 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jun 15, 2017
Insider Transaction Report
Form 4
BROWN JAMES F
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-14+10,000→ 10,000 totalExercise: $10.34Exp: 2027-06-13→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2018 Annual Meeting of stockholders.